{
  "meta": {
    "title": "Evaluation of abnormal uterine bleeding",
    "url": "https://brainandscalpel.vercel.app/evaluation-of-abnormal-uterine-bleeding-6a304dd7-cf563c.html",
    "scrapedAt": "2025-12-01T04:53:31.428Z",
    "type": "article"
  },
  "content": "\n                <div><h1>Introduction</h1>\n<p>Abnormal uterine bleeding (AUB) is a common gynecological issue that refers to uterine bleeding that is irregular in volume, duration, or timing.&nbsp; It can affect women of all ages and can be due to both structural and nonstructural causes.</p><br><br><p>This article focuses on causes and basic evaluation of AUB; additional information on the various etiologies can be found in additional articles.</p>\n<h1>Terminology</h1><br><br><p>The menstrual cycle has a set of parameters that help define normal menses.&nbsp; Patients typically have menstrual bleeding every 24-38 days, &lt;8 days of bleeding, and blood loss that does not interfere with daily activities (classically defined as &lt;80 mL of blood).</p><br><br><p>Patients with AUB have:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Irregular menstrual blood loss volume</strong>:&nbsp; either heavy or light bleeding</li>\n\t<li><strong>Irregular timing</strong>:&nbsp; absent, infrequent, or frequent menstrual cycles (eg, amenorrhea, menstrual cycles &lt;24 or &gt;38 days)</li>\n\t<li><strong>Irregular duration</strong>:&nbsp; usually prolonged (&gt;8 days of bleeding)</li>\n\t<li><strong>Intermenstrual bleeding</strong>:&nbsp; regular menses plus bleeding between menstrual cycles (eg, postcoital bleeding)</li>\n</ul>\n<h1>Causes</h1><br><br><p>Causes of AUB can be categorized into structural and nonstructural factors, which are classified using the PALM-COEIN system.</p>\n<h2>Structural causes: PALM</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>P</strong>olyp:&nbsp; endometrial or cervical polyps; typically causes intermenstrual bleeding</li>\n\t<li><strong>A</strong>denomyosis:&nbsp; endometrial glands and stroma within the myometrium; causes painful, heavy menses</li>\n\t<li><strong>L</strong>eiomyoma (fibroids):&nbsp; benign smooth muscle tumors of the uterine myometrium; causes heavy, prolonged bleeding</li>\n\t<li><strong>M</strong>alignancy and hyperplasia (endometrial hyperplasia/cancer):&nbsp; uncontrolled endometrial proliferation; causes irregular and/or heavy bleeding</li>\n</ul>\n<h2>Nonstructural causes: COEIN</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>C</strong>oagulopathy (eg, von Willebrand disease, thrombocytopenia):&nbsp; results in heavy bleeding</li>\n\t<li><strong>O</strong>vulatory dysfunction:&nbsp; anovulation or irregular ovulation (eg, polycystic ovary syndrome [PCOS], thyroid disorder, hypothalamic amenorrhea); causes amenorrhea or irregular menses</li>\n\t<li><strong>E</strong>ndometrial:&nbsp; disorders that affect the endometrial lining (eg, endometritis, intrauterine adhesions); causes irregular bleeding</li>\n\t<li><strong>I</strong>atrogenic:&nbsp; medications that can cause abnormal bleeding (eg, contraceptive pills or devices, anticoagulants)</li>\n\t<li><strong>N</strong>ot yet classified:&nbsp; causes that do not fit into the previous categories</li>\n</ul>\n<h1>Evaluation</h1><h2>History</h2><br><br><p>AUB can usually be further divided into subcategories based on history and physical examination.&nbsp; In addition to menstrual history, findings in the patient's medical history can help in the diagnosis, including:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Medical history:&nbsp; underlying medical conditions, surgeries, and medications</li>\n\t<li>Obstetric history:&nbsp; causes of AUB that also cause pregnancy complications such as preterm labor, recurrent pregnancy loss, and postpartum hemorrhage</li>\n\t<li>Family history:&nbsp; evaluation for bleeding disorders and genetic mutations that increase the risk for malignancy (eg, Lynch syndrome)</li>\n</ul>\n<h2>Physical examination</h2><br><br><p>Physical examination should evaluate for signs of anemia, thyroid disease, and hyperandrogenism.&nbsp; Pelvic examination should confirm that the bleeding is uterine in origin.&nbsp; The uterus should be palpated for size, contour, tenderness, and mobility.&nbsp; The adnexa should be palpated for masses and tenderness.</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>An irregular uterine contour or enlarged uterus suggests uterine leiomyoma.</li>\n\t<li>A tender, boggy uterus suggests adenomyosis.</li>\n\t<li>A tender, immobile uterus suggests endometriosis.</li>\n</ul>\n<h2>Laboratory evaluation</h2><br><br><p>Basic laboratory evaluation of all patients with AUB includes:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Pregnancy test</strong></li>\n\t<li><strong>Complete blood count</strong> to quantify blood loss and evaluate for anemia</li>\n\t<li><strong>Serum TSH, FSH, and prolactin levels</strong> to evaluate for hypothalamic-pituitary-ovarian axis abnormalities, which cause anovulation</li>\n</ul><br><br><p>In some patients, additional testing can include:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Coagulation studies if a bleeding disorder is suspected</li>\n\t<li>Serum testosterone and dehydroepiandrosterone sulfate levels if no signs of hyperandrogenism are present</li>\n</ul>\n<h2>Imaging</h2><br><br><p>In all gynecologic conditions, the most common imaging modality is transvaginal ultrasonography, which can evaluate the endometrium, myometrium, and adnexa for structural abnormalities.&nbsp; In some patients with suspected pathology in the uterine cavity, sonohysterography (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L81433.jpg\" alt=\"figure 1\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 1</div>\n                                </div>\n                                ), in which the uterine cavity is filled with a saline infusion, is used to better visualize intrauterine structures (eg, endometrial polyp, leiomyoma).<p></p>\n<h1>Biopsy</h1><br><br><p>An endometrial biopsy (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/108252.mp4\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: video 1\n                                    </a>\n                                </div>\n                                ) is not indicated in all cases of AUB, but it is performed in patients with suspected endometrial hyperplasia and/or cancer.&nbsp; Indications include:<p></p><br><br><ul class=\"article-body-unordered-list\">\n\t<li>Age â‰¥45 with AUB (ie, the risk of endometrial cancer increases with age)</li>\n\t<li>Age &lt;45 with AUB plus:\n\t<ul class=\"article-body-unordered-list\">\n\t\t<li>Unopposed estrogen (eg, obesity, PCOS)</li>\n\t\t<li>Failed medical management</li>\n\t\t<li>Lynch syndrome</li>\n\t</ul>\n\t</li>\n\t<li>Age â‰¥35 with atypical glandular cells on Pap test (ie, the atypical cells can be of endocervical or endometrial origin)</li>\n</ul>\n<h1>Management</h1><br><br><p>Most cases of AUB, regardless of the etiology, are managed with a similar goal of menstrual regulation to improve the patient's quality of life and to prevent complications (eg, endometrial cancer, anemia).</p><br><br><p>This is most commonly accomplished medically with contraceptive options, including:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Combined estrogen/progestin oral contraceptive pills</strong>:&nbsp; regulate endometrial thickness and shedding</li>\n\t<li><strong>Progestin-only contraception</strong> (including implants, intrauterine devices, or intramuscular injections):&nbsp; decreases the endometrial lining</li>\n\t<li><strong>GnRH agonists</strong> (eg, leuprolide):&nbsp; decrease the release of FSH and LH, resulting in amenorrhea.&nbsp; Typically used only as a bridging therapy prior to surgical management in patients with heavy menstrual bleeding to improve anemia.</li>\n</ul><br><br><p>Patients whose condition does not improve with medical therapy are offered surgical management with:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Endometrial ablation</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L84983.jpg\" alt=\"figure 2\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 2</div>\n                                </div>\n                                ):&nbsp; typically used in patients with heavy menstrual bleeding without intrauterine pathology; surgically obliterates the endometrium to prevent menses</li>\n\t<li><strong>Myomectomy</strong>:&nbsp; removal of uterine fibroids to decrease the endometrial surface area</li>\n\t<li><strong>Uterine artery embolization</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L85092.jpg\" alt=\"figure 3\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 3</div>\n                                </div>\n                                ):&nbsp; decreases blood flow to the uterus but preferentially decreases blood flow to uterine fibroids</li>\n\t<li><strong>Hysterectomy</strong>:&nbsp; definitive management</li>\n</ul>\n<h1>Summary</h1><br><br><p>Abnormal uterine bleeding is a common gynecologic condition related to uterine bleeding that is irregular in volume, duration, or timing.&nbsp; Causes are both structural and nonstructural in nature; medical management of most causes involves the goal of menstrual regulation.</p>\n</div>\n\n            "
}